Source: Basic & Clinical Pharmacology & Toxicology. Unidade: ICB
Subjects: FARMACOLOGIA, MIÓCITOS DE MÚSCULO LISO, MÚSCULO LISO VASCULAR, CONTRAÇÃO MUSCULAR, RECEPTORES DE DOPAMINA, AORTA TORÁCICA, CÁLCIO, RATOS, SINERGISMO DE DROGAS
ABNT
BRITTO JUNIOR, José et al. 6-nitrodopamine potentiates catecholamine-induced Ca2+i release in human aortic smooth muscle and modulates vascular smooth muscle contractility. Basic & Clinical Pharmacology & Toxicology, v. 138, p. 14 , 2026Tradução . . Disponível em: https://doi.org/10.1111/bcpt.70224. Acesso em: 01 maio 2026.APA
Britto Junior, J., Qiao, S., Tang, H. F., Cardenas, V., Antunes, E., De Nucci, G., et al. (2026). 6-nitrodopamine potentiates catecholamine-induced Ca2+i release in human aortic smooth muscle and modulates vascular smooth muscle contractility. Basic & Clinical Pharmacology & Toxicology, 138, 14 . doi:10.1111/bcpt.70224NLM
Britto Junior J, Qiao S, Tang HF, Cardenas V, Antunes E, De Nucci G, Ferro A, Lima AT. 6-nitrodopamine potentiates catecholamine-induced Ca2+i release in human aortic smooth muscle and modulates vascular smooth muscle contractility [Internet]. Basic & Clinical Pharmacology & Toxicology. 2026 ; 138 14 .[citado 2026 maio 01 ] Available from: https://doi.org/10.1111/bcpt.70224Vancouver
Britto Junior J, Qiao S, Tang HF, Cardenas V, Antunes E, De Nucci G, Ferro A, Lima AT. 6-nitrodopamine potentiates catecholamine-induced Ca2+i release in human aortic smooth muscle and modulates vascular smooth muscle contractility [Internet]. Basic & Clinical Pharmacology & Toxicology. 2026 ; 138 14 .[citado 2026 maio 01 ] Available from: https://doi.org/10.1111/bcpt.70224
